Assertio Holdings, Inc. (ASRT)
About Assertio Holdings, Inc.
Assertio Holdings Inc is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs. The group's focus is on supporting patients by marketing oncology, neurology, and pain management products.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $118.7M
- Net income
- -$30.4M
- Total assets
- $267.0M
- Market cap
- $151.5M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $151.5M
- Shares outstanding
- 6.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 5, 1997
Assertio Holdings, Inc. (ASRT) Stock Price
- Reported a net loss of $30.4M in FY2025.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Assertio Holdings, Inc..
Write a review
News about Assertio Holdings, Inc.
News & sentiment via Polygon.io
Assertio Holdings, Inc.: frequently asked questions
Is Assertio Holdings, Inc. an American company?
Assertio Holdings, Inc. is a US-based company headquartered in Lake Forest, Illinois, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Assertio Holdings, Inc. headquartered?
Assertio Holdings, Inc. is headquartered in Lake Forest, Illinois, United States.
Is Assertio Holdings, Inc. publicly traded?
Yes — Assertio Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol ASRT on the NASDAQ.
What does Assertio Holdings, Inc. do?
Assertio Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
